The impact of SARS-CoV-2 vaccination and infection on neutralising antibodies: a nation-wide cross-sectional analysis.

Thomas AlthausJordi LandierFeng ZhuHervé RapsOlivier DejouxAlizée CostantiniChristian LavagnaPatrick RampalGiada MattiuzzoShuting XuLin-Fa WangEric Voiglio

Published in: The Journal of infectious diseases (2023)

Hybrid immunity provided stable, high and consistent nAbs over time. The benefit of boosters was marked to restore decaying nAbs in uninfected participants. NAbs could identify individuals at risk of severe COVID-19 and provide more targeted vaccine boosters' campaigns.

Keyphrases

sars cov
cross sectional
respiratory syndrome coronavirus
coronavirus disease
hiv infected
cancer therapy
drug delivery
data analysis